Anti-p53 FITC
The tumour suppressor protein p53 is a key element of intracellular anticancer protection. It mediates cell cycle arrest or apoptosis in response to DNA damage or to starvation for pyrimidine nukleotides. It is up-regulated in response to these stress signals and stimulated to activate transcription of specific genes, resulting in expression of p21waf1 and other proteins involved in G1 or G2/M arrest, or proteins that trigger apoptosis, such as Bcl-2. The structure of p53 comprises N-terminal transactivation domain, central DNA-binding domain, oligomerisation domain, and C-terminal regulatory domain. There are various phosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53 activation and stabilization.
Product Specifications
Certification
RUO
Reactivity
Human, Non-human primates
Immunogen
Bacterially expressed full-length wild-type p53
Target Antigen
P53
Clone
BP53-12
Applications
FC-IC (QC tested)
Concentration
1 mg/mL
Format
FITC
Buffer
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations
Other References
Storage Conditions
Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
Specificity
Applications Notes
Flow cytometry: Recommended dilution: 3 μg/ml. Intracellular staining.
Isotype
Mouse IgG2a
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items